期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

罗格列酮对空腹血糖受损患者血清可溶性E选择素水平的影响

Effect of rosiglitazone on soluble E-selectin level in patients with isolated impaired fasting glucose
原文传递
导出
摘要 空腹血糖受损患者接受罗格列酮治疗(RGZ组,n=39)与否(non-RGZ组,n=20)的研究显示,可溶性E选择素血浓度(μg/L)治疗后比治疗前降低(45±14 vs 50±15),安慰剂组治疗前后无统计学变化(51±15 vs 51±16)。 The study of impaired fasting glucose （IFG） patients undergoing rosiglitazome （RGZ,n=39）therapy or not（non-RGZ,n=20）showed that the sE-seleetin level （μg/L）was decreased in RGZ versus non-RGZ group after therapy （45 ± 14 vs 51 ± 15）,in RGZ group after vs before therapy （45±14 vs 50±15）,and did not change in non-RGZ group post-vs pre-treatment （51±15 vs 51±16）.
作者 傅绪栋 赵宗进 陈研修 司明文
机构地区 山东省聊城市人民医院
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第3期192-193,共2页 Chinese Journal of Diabetes
关键词 罗格列酮 E选择素 单纯空腹血糖受损 Rosiglitazone E-seleetin Isolated impaired fasting glucose
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献7

  • 1Natali A,Baldeweg S.Toschi E,et al.Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.Diabetes care,2004,27:1349-1357
  • 2Bevilacqua MP.Endothelial leukocyte adhesion molecues.Annu Rev Immunol,1993,11:767-804.
  • 3章建梁,秦永文,郑兴,邱健力,张乐之,张建荣,邹大进.原发性高血压患者血清可溶性E选择素水平与胰岛素抵抗的关系[J].中国病理生理杂志,2004,20(10):1856-1860. 被引量：2
  • 4Chu JW,Abbasi F,Lamendola C,et al.Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects.Diab Vasc Dis Res,2005,2:37-41.
  • 5Albertini JP,McMom SO,Chen H,et al.Effect of rosiglitazone on factors related to endothelial dysfunction in patients with type 2 diabetes mellitus.Atherosclerosis,2007,195:E159-E166.
  • 6Hetzel J,Balletshofer B,Rittig K,et al Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers.Arterioscler Thromb Vase Biol,2005,25:1804-1809.
  • 7Johns DG,Ao Z,Eybye M,et al.Rosiglitazone protects against ischemia/reperfusion-induced leukocyte adhesion in the zucker diabetic fatty rat.J Pharmacol Exp Ther,2005,315:1020-1027.

二级参考文献15

  • 1Bevilacqua MP. Endothelial-leukocyte adhesion molecules[J]. Annu Rev Immunol, 1993, 11(6):767-804.
  • 2Ballantyne CM. Newer risk markers and surrogate endpoints in atherosclerosis management[J]. Clin Cardiol, 2001, 24(Suppl 8): III13-III17.
  • 3Bluher M, Unger R, Rassoul F, et al. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes[J]. Diabetologia, 2002, 45(2):210-216.
  • 4Targher G, Bonadonna RC, Alberiche M, et al. Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue[J]. Diabetes Care, 2001, 24(11):1961-1966.
  • 5DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance[J]. Am J Physiol, 1979, 237(3):E214-E223.
  • 6Demerath E, Towne B, Blangero J, et al. The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women[J]. Ann Hum Biol, 2001, 28(Suppl 1): 664-678.
  • 7Matsumoto K, Sera Y, Nakamura H, et al. Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus[J]. Diabetes Res Clin Pract, 2002, 55(2):131-138.
  • 8Koh KK, Ahn JY, Jin DK, et al. Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women[J]. Arterioscler Thromb Vasc Biol, 2002, 22(9):1459-1464.
  • 9Ascott-Evans B. The metabolic syndrome, insulin resistance and cardiovascular disease[J]. Cardiovasc J S Afr, 2002, 13(4):187-188.
  • 10Wong KY, MacWalter RS, Fraser HW, et al. Urate predicts subsequent cardiac death in stroke survivors[J]. Eur Heart J, 2002, 23(10):788-793.

共引文献1

中国糖尿病杂志
2009年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部